Archive | Melanoma News

World Melanoma Month 2021 – SBS News

On Saturday MPA launched a major public awareness campaign to highlight World Melanoma Month.

Read the full story

Posted in Melanoma News, Patients, Latest News

Relatlimab-nivolumab combination extends PFS in metastatic melanoma

A trial designed to evaluate the addition of relatlimab to nivolumab for untreated metastatic or unresectable melanoma met its primary endpoint of improved PFS, according to topline data released by the agent’s manufacturer.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

Combination Treatment Improves Relapse-Free Survival Time

Patients with stage III melanoma receiving a combination treatment of dabrafenib (Tafinlar) and trametinib (Mekinist) achieved longer restricted mean survival times (RMST) compared to placebo, according to recent study results.1

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Relatlimab/Nivolumab Improves PFS in Previously Untreated Metastatic or Unresectable Melanoma

The fixed-dose combination of relatlimab plus nivolumab (Opdivo) was found to improve progression-free survival (PFS) over nivolumab alone in patients with previously untreated metastatic or unresectable melanoma, meeting the primary end point of the phase 2/3 RELATIVITY-047 (CA224-047; NCT03470922) trial.1

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest